Identification of transferrin receptor 1 as a hepatitis C virus entry factor

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 26, 2013, Pages 10777-10782

  Martin, Danyelle N ^a,b   Uprichard, Susan L ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Hepatic iron overload; Viral entry factor

Indexed keywords

BLOCKING ANTIBODY; CD71 ANTIGEN; GLYCOPROTEIN E2; IRON; SMALL INTERFERING RNA; VIRUS RNA;

ARTICLE; CELL SURFACE; ENDOCYTOSIS; GENE SILENCING; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INTERNALIZATION; IRON METABOLISM; IRON OVERLOAD; IRON TRANSPORT; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; VIRUS ENTRY; VIRUS PARTICLE; VIRUS REPLICATION;

HEPATIC IRON OVERLOAD; VIRAL ENTRY FACTOR;

ANTIGENS, CD; ANTIGENS, CD81; CELL LINE; GENE KNOCKDOWN TECHNIQUES; HEPACIVIRUS; HEPATITIS C, CHRONIC; HOST-PATHOGEN INTERACTIONS; HUMANS; IRON; RECEPTORS, TRANSFERRIN; RNA, SMALL INTERFERING; VIRUS INTERNALIZATION; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 84879549180     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1301764110     Document Type: Article

References (38)

1. Asselah T, Marcellin P (2011) New direct-acting antivirals' combination for the treatment of chronic hepatitis C. Liver Int 31(Suppl 1):68-77.
2. Chopra A, Klein PL, Drinnan T, Lee SS (2013) How to optimize HCV therapy in genotype 1 patients: Management of side-effects. Liver Int 33(Suppl 1):30-34.
3. Fujita N, et al. (2007) Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients. Free Radic Biol Med 42(3):353-362.
4. Fujita N, et al. (2007) Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C. J Gastroenterol Hepatol 22(11):1886-1893.
5. Haque S, Chandra B, Gerber MA, Lok AS (1996) Iron overload in patients with chronic hepatitis C: A clinicopathologic study. Hum Pathol 27(12):1277-1281.
6. Kaito M (2007) Molecular mechanism of iron metabolism and overload in chronic hepatitis C. J Gastroenterol 42(1):96-99.
7. Fillebeen C, et al. (2007) Expression of the subgenomic hepatitis C virus replicon alters iron homeostasis in Huh7 cells. J Hepatol 47(1):12-22.
8. Hagist S, et al. (2009) In vitro-targeted gene identification in patients with hepatitis C using a genome-wide microarray technology. Hepatology 49(2):378-386.
9. Tosoni D, et al. (2005) TTP specifically regulates the internalization of the transferrin receptor. Cell 123(5):875-888.
10. Parker JS, Murphy WJ, Wang D, O'Brien SJ, Parrish CR (2001) Canine and feline parvoviruses can use human or feline transferrin receptors to bind, enter, and infect cells. J Virol 75(8):3896-3902.
11. Radoshitzky SR, et al. (2007) Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature 446(7131):92-96.
12. Wang E, et al. (2008) Mouse mammary tumor virus uses mouse but not human transferrin receptor 1 to reach a low pH compartment and infect cells. Virology 381 (2):230-240.
13. Barth H, et al. (2003) Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J Biol Chem 278(42):41003-41012.
14. Germi R, et al. (2002) Cellular glycosaminoglycans and low density lipoprotein receptor are involved in hepatitis C virus adsorption. J Med Virol 68(2):206-215.
15. Gardner JP, et al. (2003) L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus. Proc Natl Acad Sci USA 100(8):4498-4503.
16. Lozach PY, et al. (2003) DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. J Biol Chem 278(22):20358-20366.
17. Monazahian M, et al. (1999) Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J Med Virol 57(3):223-229.
18. Agnello V, Abel G, Elfahal M, Knight GB, Zhang QX (1999) Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci USA 96(22):12766-12771.
19. Scarselli E, et al. (2002) The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 21(19):5017-5025.
20. Zeisel MB, et al. (2007) Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81. Hepatology 46(6):1722-1731.
21. Pileri P, et al. (1998) Binding of hepatitis C virus to CD81. Science 282(5390):938-941.
22. Zhang J, et al. (2004) CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J Virol 78(3):1448-1455.
23. Evans MJ, et al. (2007) Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446(7137):801-805.
24. Ploss A, et al. (2009) Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457(7231):882-886.
25. Sainz B, Jr., et al. (2012) Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor. Nat Med 18(2):281-285.
26. Lupberger J, et al. (2011) EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat Med 17(5):589-595.
27. Sainz B, Jr., Chisari FV (2006) Production of infectious hepatitis C virus by well-differentiated, growth-arrested human hepatoma-derived cells. J Virol 80(20): 10253-10257.
28. Wakita T, et al. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11(7):791-796.
29. Horonchik L, Wessling-Resnick M (2008) The small-molecule iron transport inhibitor ferristatin/NSC306711 promotes degradation of the transferrin receptor. Chem Biol 15(7):647-653.
30. Timpe JM, et al. (2008) Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies. Hepatology 47(1):17-24.
31. Koutsoudakis G, et al. (2006) Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J Virol 80(11):5308-5320.
32. Diao J, et al. (2012) Hepatitis C virus induces epidermal growth factor receptor activation via CD81 binding for viral internalization and entry. J Virol 86(20): 10935-10949.
33. Bankwitz D, et al. (2010) Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes. J Virol 84(11):5751-5763.
34. Radoshitzky SR, et al. (2008) Receptor determinants of zoonotic transmission of New World hemorrhagic fever arenaviruses. Proc Natl Acad Sci USA 105(7):2664-2669.
35. Farquhar MJ, et al. (2012) Hepatitis C virus induces CD81 and claudin-1 endocytosis. J Virol 86(8):4305-4316.
36. Coller KE, et al. (2009) RNA interference and single particle tracking analysis of hepatitis C virus endocytosis. PLoS Pathog 5(12):e1000702.
37. Krieger N, Lohmann V, Bartenschlager R (2001) Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J Virol 75(10):4614-4624.
38. Yu X, Uprichard SL (2010) Cell-based HCV infection fluorescence resonance energy transfer (FRET) assay for antiviral compound screening. Curr Protoc Microbiol Chap 17:Unit 17.15.